118. One team, one mission: tackling pruritus, Chris Posner, President & CEO, Cara Therapeutics
Christopher Posner Chief Executive Officer, President, and Director Mr. Posner has served as our President and Chief Executive Officer since November 2021 and has served as a member of our Board sinc...
14 Sep 202234min
117. Pioneering cell biology drug discovery, Rachel Meyers, CSO, Faze Medicines
Rachel Meyers serves as the chief scientific officer at Faze Medicines. She was most recently an entrepreneur-in-residence at Third Rock Ventures (TRV), where she helped drive the creation of Faze Me...
31 Aug 202223min
116. Retinal restoration and visions for growth, Brian Culley, CEO, Lineage Cell Therapeutics
Mr. Culley joined Lineage as Chief Executive Officer in September 2018. Prior to joining Lineage, Mr. Culley served from August 2017 to September 2018 as interim Chief Executive Officer at Artemis The...
24 Aug 202217min
115. Innovations in diabetes therapies, Timothy Kieffer, CSO, Manasi Sinha Jaiman, CMO, ViaCyte
Timothy Kieffer Dr. Kieffer has a deep knowledge of gene and cell therapies, regenerative medicine, diabetes applied research, and industry experience. As Chief Scientific Officer, he leads ViaCyte’s ...
17 Aug 202218min
114. Advancing cell therapy and multiple myeloma treatment, Ying Huang, CEO, Legend Biotech
Dr. Ying Huang currently serves as Chief Executive Officer of Legend Biotech. He sits on the Board of Directors of Legend, as well as Quanta Therapeutics. Dr. Huang brings over 9 years of experience ...
10 Aug 202223min
113. Envisioning VDC cancer treatment, Elisabet de los Pinos, CEO, Aura Biosciences
Eli de los Pinos is the founding CEO of Aura, which she has created from the ground up: She developed the company concept and has spearheaded fundraising efforts, and today, she continues to lead Aura...
3 Aug 202220min
112. New approaches in CNS diseases, Brad Margus, Co-founder and Executive Chairman, Cerevance
Brad Margus is co-founder and Executive Chairman of Cerevance, a drug discovery company advancing a robust pipeline of targeted treatments for patients with neurodegenerative diseases, including Parki...
27 Juli 202223min
111. Synthetic biology & probiotics, Aoife Brennan, President & CEO, Synlogic
Dr. Aoife Brennan is an experienced physician scientist and drug developer responsible for the successful clinical development and registration of multiple transformative medicines. Aoife has served a...
20 Juli 202230min
